Latest Merck Stories
Data From Two Separate Phase 3 Studies of Evolocumab (AMG 145), a PCSK9 Inhibitor, Presented in Late-Breaking Clinical Trials Session at ACC.14 - Data Add to the Three Pivotal Studies Presented Yesterday THOUSAND
Pharmica Consulting, the industry leader in life science processes and technology, is pleased to announce that Arnaub Chatterjee of Merck will speak at Pharmica’s Pharma 3.0 – The Digital
LONDON, March 27, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
ANN ARBOR, Mich., March 26, 2014 /PRNewswire/ -- NanoBio Corporation today announced a licensing agreement with a subsidiary
PHOENIX, March 25, 2014 /PRNewswire/ -- Today, Insiderslab.com released the latest insider trading research for Ariad Pharmaceuticals (NASDAQ:ARIA), Cell Therapeutics (NASDAQ:CTIC),
DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/rq8jml/investigation) has announced the addition of the "Investigation
LONDON, March 18, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
BOSTON, March 7, 2014 /PRNewswire/ -- Columbia Laboratories, Inc.
BOSTON, Mar. 3, 2014 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) announced today that Donald H.